🔎 Trials Near Me

Home › Steatotic Liver Disease › California › Los Angeles

Steatotic Liver Disease clinical trials in Los Angeles, CA

8 studies for Steatotic Liver Disease are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

RecruitingPhase 3
  • 89bio Clinical Study Site, Los Angeles
  • 89bio Clinical Study Site, Los Angeles
Ages 18 to 75 · All sexes · Updated Oct 5, 2026 · NCT06419374

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

RecruitingPhase 2
  • Keck Medical Center of USC, Los Angeles
  • LAC + USC Medical Center, Los Angeles
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT05832229

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

RecruitingPhase 3
  • Los Angeles Institute for Metabolic Research, Los Angeles
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

RecruitingPhase 3
  • Akero Clinical Study Site, Los Angeles
Ages 18 to 80 · All sexes · Updated Sep 21, 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

RecruitingPhase 3
  • GSK Investigational Site, Los Angeles
Ages 18 to 75 · All sexes · Updated Sep 17, 2026 · NCT07221188

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

RecruitingPhase 2
  • GSK Investigational Site, Los Angeles
  • GSK Investigational Site, Los Angeles
Ages 18 to 70 · All sexes · Updated Aug 3, 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

RecruitingPhase 3
  • GSK Investigational Site, Los Angeles
Ages 18 to 75 · All sexes · Updated Jul 27, 2026 · NCT07221227

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

RecruitingPhase 1/2Healthy volunteers welcome
  • Velocity Clinical research, Los Angeles
Ages 18 to 75 · All sexes · Updated Apr 16, 2026 · NCT05648214

About Steatotic Liver Disease

Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.

More about Steatotic Liver Disease on MedlinePlus

Steatotic Liver Disease trials in other cities

Other studies in Los Angeles

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.